Literature DB >> 404036

Progesterone and progesterone receptors in experimental breast cancer.

K B Horwitz, W L McGuire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404036

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  18 in total

1.  Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.

Authors:  B M Sherman; F K Chapler; K Crickard; D Wycoff
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

2.  Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu receptor coexpression.

Authors:  Marina Barić; Ana Kulić; Maja Sirotković-Skerlev; Natalija Dedić Plavetić; Marina Vidović; Gordana Horvatić-Herceg; Damir Vrbanec
Journal:  Pathol Oncol Res       Date:  2014-11-04       Impact factor: 3.201

3.  Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma.

Authors:  B Uzarević; M Petrovecki; M Marusić; J Jakić-Razumović; Z Hutinec; A Sabioncello; S Gamulin
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.

Authors:  R J Moore; J M Gazak; J D Wilson
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

5.  Distinction between progestin- and glucocorticoid-binding sites in mammary glands. Apparent lack of cytoplasmic progesterone receptors in lactating mammary glands.

Authors:  G Shyamala; W A McBlain
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

6.  Peroxidase activity (PA) and progesterone receptors (PgR) in normal rat mammary glands.

Authors:  R Seshadri; A P Banerji; P N Shah
Journal:  Experientia       Date:  1983-02-15

7.  Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer.

Authors:  C Sumida; H Magdelenat; J R Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

8.  The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice.

Authors:  M R Schneider; H Michna; U F Habenicht; Y Nishino; H J Grill; K Pollow
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Prolactin binding by human mammary carcinoma: relationship to estrogen receptor protein concentration and patient age.

Authors:  B Rae-Venter; T Nemoto; S L Schneider; T L Dao
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

10.  Changes in the hormone dependency of DMBA-induced rat mammary tumors with reference to the effect of tamoxifen.

Authors:  K Inui; T Morimoto; K Komaki; H Sonoo; Y Monden
Journal:  Jpn J Surg       Date:  1988-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.